| Patient | Frederick Law Olmsted |
|---|---|
| Date of birth | 1953-04-26 |
| Identifiers | MRN HR-NI022-SYN; SSN (made up) 000-22-5519 |
| Document date | 2026-05-05 |
| Author | Nathan Calder, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Progressive memory loss over about two years in a 73-year-old landscape architect who has had to step back from his practice. Please confirm whether this is dementia or mild cognitive impairment, advise on the likely type and on biomarker testing, advise on treatment, and advise on driving. [S]
Urgency: Routine, within four weeks, on the same day as his results visit. [S]
Questions for the consultant:
About two years of worsening memory: repeats questions, loses track of letters and project plans, misses appointments without reminders; he stepped back from his practice this year because of it. History from him and his caregiver. MoCA 19 of 30, losing points on delayed recall (1 of 5), orientation to date, clock drawing, trail-making, and fluency. Katz ADL 6 of 6; Lawton IADL 5 of 8 (help with finances, medicines, and travel planning). NPI-Q: mild irritability and apathy. PHQ-9 6, without thoughts of self-harm. Timed Up and Go 11 seconds; no falls; normal gait. Blood count, metabolic panel, albumin, ALT, vitamin B12 410 pg/mL, folate, and TSH 1.9 all normal; syphilis and HIV not tested, as he has no risk factors. MRI of the brain two weeks after the first visit: generalized cortical atrophy beyond that expected for age, mild bilateral medial temporal atrophy (MTA score 2), and Fazekas grade 1 white-matter change, without infarct, mass, or hydrocephalus. No medicines. Still driving short familiar routes. No firearms at home. Pulse 72 and blood pressure 134/78 mmHg at the first visit [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairment | active | confirmed | R41.3 | S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D). |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1863 | Exhaustion and illness from overwork while leading a national wartime relief commission, ending in his resignation in 1863; illness not specified in the cited source | D (CLM-0009) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-05 | Body height | 175 | cm | S |
| 2026-05-05 | Body weight | 72 | kg | S |
| 2026-05-05 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 2026-05-05 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-05-05 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-05-05 | Heart rate | 72 | /min | S |
| 2026-05-05 | Respiratory rate | 14 | /min | S |
| 2026-05-05 | Body temperature | 36.7 | Cel | S |
| 2026-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-05 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-05-05 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-05-05 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 2026-05-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-05-05 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-05 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-05-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 76 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-05-05 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-05-05 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-05-05 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-05-05 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-55 U/L | Normal | S |
| 2026-05-05 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-05-05 | Folate [Mass/volume] in Serum or Plasma | 12.4 | ng/mL | >=5.9 ng/mL | Normal | S |
| 2026-05-05 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-05-05 | Total score [MoCA] | 19 | {score} | S | ||
| 2026-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |